17-65053600-C-G

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_006572.6(GNA13):ā€‹c.412G>Cā€‹(p.Glu138Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000309 in 1,613,668 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00031 ( 0 hom., cov: 33)
Exomes š‘“: 0.00031 ( 0 hom. )

Consequence

GNA13
NM_006572.6 missense

Scores

4
7
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.57
Variant links:
Genes affected
GNA13 (HGNC:4381): (G protein subunit alpha 13) Predicted to enable D5 dopamine receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Predicted to be involved in several processes, including Rho protein signal transduction; activation of phospholipase D activity; and multicellular organism aging. Predicted to act upstream of or within several processes, including branching involved in blood vessel morphogenesis; negative regulation of vascular associated smooth muscle cell migration; and negative regulation of vascular associated smooth muscle cell proliferation. Located in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High AC in GnomAd4 at 47 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GNA13NM_006572.6 linkuse as main transcriptc.412G>C p.Glu138Gln missense_variant 2/4 ENST00000439174.7
GNA13NM_001282425.2 linkuse as main transcriptc.127G>C p.Glu43Gln missense_variant 2/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GNA13ENST00000439174.7 linkuse as main transcriptc.412G>C p.Glu138Gln missense_variant 2/41 NM_006572.6 P1Q14344-1
GNA13ENST00000541118.1 linkuse as main transcriptc.127G>C p.Glu43Gln missense_variant 2/42 Q14344-2

Frequencies

GnomAD3 genomes
AF:
0.000309
AC:
47
AN:
152184
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000302
AC:
76
AN:
251490
Hom.:
0
AF XY:
0.000338
AC XY:
46
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000392
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000492
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000309
AC:
452
AN:
1461366
Hom.:
0
Cov.:
30
AF XY:
0.000326
AC XY:
237
AN XY:
727054
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000313
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000355
Gnomad4 OTH exome
AF:
0.000282
GnomAD4 genome
AF:
0.000309
AC:
47
AN:
152302
Hom.:
0
Cov.:
33
AF XY:
0.000255
AC XY:
19
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000529
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000410
Hom.:
0
Bravo
AF:
0.000212
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000264
AC:
32
EpiCase
AF:
0.000654
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 28, 2022The c.412G>C (p.E138Q) alteration is located in exon 2 (coding exon 2) of the GNA13 gene. This alteration results from a G to C substitution at nucleotide position 412, causing the glutamic acid (E) at amino acid position 138 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.069
T
BayesDel_noAF
Uncertain
-0.010
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D;.
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.85
T;T
M_CAP
Benign
0.037
D
MetaRNN
Uncertain
0.57
D;D
MetaSVM
Uncertain
0.087
D
MutationAssessor
Benign
1.8
L;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.9
N;N
REVEL
Pathogenic
0.66
Sift
Benign
0.059
T;T
Sift4G
Uncertain
0.057
T;T
Polyphen
1.0
D;.
Vest4
0.69
MVP
0.83
MPC
0.89
ClinPred
0.098
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.27
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141288232; hg19: chr17-63049718; COSMIC: COSV105830103; COSMIC: COSV105830103; API